Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Hawkey

Showing results (1-10 of 279) with videos related to

Pageof 28
Sort By:
Best Practice & Research. Clinical Gastroenterology|September 22, 2001
COX-1 and COX-2 inhibitorsC J Hawkey
BMJ (Clinical Research Ed.)|July 29, 2000
Outcomes studies of drug induced ulcer complications: do we need them and how should they be done?C J Hawkey
BMJ (Clinical Research Ed.)|December 4, 2001
Journals should see original protocols for clinical trialsC J Hawkey
Clinical and Experimental Rheumatology|November 7, 2001
NSAIDs and COX-2 inhibitors: what can we learn from large outcomes trials? The gastroenterologist's perspectiveC J Hawkey
The American Journal of Medicine|February 13, 2001
Nonsteroidal anti-inflammatory drugs and the gastrointestinal tract: consensus and controversy. IntroductionC J Hawkey
Digestive Diseases (Basel, Switzerland)|February 2, 2017
Hematopoietic Stem Cell Transplantation in Crohn's Disease: State-of-the-Art TreatmentC J Hawkey
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|December 1, 1994
Mechanisms of gastric mucosal damageC J Hawkey
Alimentary Pharmacology & Therapeutics|November 21, 2012
Commentary: risk factors for gastrointestinal bleeding in NSAID usersC J Hawkey
Gut|October 18, 2005
COX-2 chronologyC J Hawkey
Gut|April 16, 2002
Cyclooxygenase inhibition: between the devil and the deep blue seaC J Hawkey
Pageof 28

Showing results (1-10 of 279) with videos related to

Sort By:
Pageof 28
Best Practice & Research. Clinical Gastroenterology|September 22, 2001
COX-1 and COX-2 inhibitorsC J Hawkey
BMJ (Clinical Research Ed.)|July 29, 2000
Outcomes studies of drug induced ulcer complications: do we need them and how should they be done?C J Hawkey
BMJ (Clinical Research Ed.)|December 4, 2001
Journals should see original protocols for clinical trialsC J Hawkey
Clinical and Experimental Rheumatology|November 7, 2001
NSAIDs and COX-2 inhibitors: what can we learn from large outcomes trials? The gastroenterologist's perspectiveC J Hawkey
The American Journal of Medicine|February 13, 2001
Nonsteroidal anti-inflammatory drugs and the gastrointestinal tract: consensus and controversy. IntroductionC J Hawkey
Digestive Diseases (Basel, Switzerland)|February 2, 2017
Hematopoietic Stem Cell Transplantation in Crohn's Disease: State-of-the-Art TreatmentC J Hawkey
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|December 1, 1994
Mechanisms of gastric mucosal damageC J Hawkey
Alimentary Pharmacology & Therapeutics|November 21, 2012
Commentary: risk factors for gastrointestinal bleeding in NSAID usersC J Hawkey
Gut|October 18, 2005
COX-2 chronologyC J Hawkey
Gut|April 16, 2002
Cyclooxygenase inhibition: between the devil and the deep blue seaC J Hawkey
Pageof 28